Jason Kelly is co-founder and CEO of Ginkgo Bioworks.
2 reports, 1 independent
Updated Aug 9
Gone quiet
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Jason Kelly is co-founder and CEO of Ginkgo Bioworks.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Jason Kelly
American writer, stock market specialist
Nothing else this week.
-
Ginkgo Bioworks
American biotechnology company
Nothing else this week.
Related events
Coverage
Newest first; wire copies grouped- PR NewswireGinkgo Bioworks Reports Second Quarter 2025 Financial Results Ginkgo provides an update on its restructuring, including achievement of its expanded $250 million cost savings targets BOSTON, Aug. 7, 2